About Hanall Biopharma
Hanall Biopharma is a Healthcare company based in Seoul (South Korea) founded in 1973. Biopharmaceutical firm developing drugs for ophthalmology, immunology, oncology, and neurology. It operates on a B2B and Licensing and Partnerships model. Hanall Biopharma offers products and services including Tanfanercept, Batoclimab, and Immuno-oncology Inhibitor. Its focus areas include Biopharmaceuticals, Therapeutics, Neurology and Immunology. Its legal entity is HanAll Biopharma Co., Ltd.
Company details
HanAll Biopharma is a global biopharmaceutical company headquartered in South Korea, focusing on innovative therapeutics to address unmet medical needs in areas like ophthalmology, immunology, oncology, and neurology. They conduct research, form partnerships, and manage drug pipelines through licensing agreements and clinical trials. Operating from multiple locations including Seoul, they serve healthcare professionals and patients worldwide by advancing treatments and ensuring drug safety.
- Headquarters Seoul, South Korea
- SectorsHealthcare
- Email••••••••
- Website hanall.com
- Social LinkedIn X Instagram
- Legal Name Hanall Biopharma Co., Ltd.
Products & Services of Hanall Biopharma
Hanall Biopharma offers a comprehensive portfolio of products and services, including Tanfanercept, Batoclimab, and Immuno-oncology Inhibitor.
Topical treatment for inflammatory eye diseases
Targets autoimmune diseases through FcRn inhibition
Next-generation immune checkpoint inhibitor for cancer
People of Hanall Biopharma
6 people are tracked at Hanall Biopharma (5 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Mary Bearkland | Sr. Director Clinical Operations | Leadership |
Sean Jeong | President And CEO | Leadership |
Kristin Wilborn | Director Of Biostatistics | Leadership |
Geralyn Angeles | Chief Of Staff | Leadership |
David Hernandez | Vice President, Head Of Clinical Development Operations | Leadership |
Andria White | Senior Manager, Clinical Operations | Team |
Complete people profiles for Hanall Biopharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hanall Biopharma
Complete news archive for Hanall Biopharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hanall Biopharma
Hanall Biopharma was founded in 1973.
Hanall Biopharma is headquartered in Seoul, South Korea.
HanAll Biopharma is a global biopharmaceutical company headquartered in South Korea, focusing on innovative therapeutics to address unmet medical needs in areas like ophthalmology, immunology, oncology, and neurology. They conduct research, form partnerships, and manage drug pipelines through licensing agreements and clinical trials. Operating from multiple locations including Seoul, they serve healthcare professionals and patients worldwide by advancing treatments and ensuring drug safety.
Hanall Biopharma offers Tanfanercept, Batoclimab, and Immuno-oncology Inhibitor.
Hanall Biopharma operates through Hanall Biopharma Co., Ltd..